A Study of Factors Associated with Relapse of Drinking during a 1 Year Follow-up: A Retrospective Cohort of 70 Males Treated as In-Patient for Alcohol Dependence Syndrome

Abstract

Relapse is a multi-factorial phenomenon and most likely to result from a combination of various factors. This study was conducted to determine factors associated with relapse of drinking in patients who underwent deaddiction treatment programme. Material and Methods: This is a retrospective cohort study was done in patients who were admitted for in-patient deaddiction care programme between September 2017 and February 2018. The in-patient charts of the subjects were retrieved from the medical records department. The SADQ score at admission, CIWA-Ar score and The Brief Substance Craving Score at the time of discharge were taken from the record. Results: A total of 70 patients were recruited and the mean age of participant was 41.27 ± 11.07 years. At the end of 1 year the mean total no. of lapses was 9.9 ± 12.67 in the study population and the mean total number of relapses was 0.84 ± 0.94. The mean duration of complete abstinence last 1 year (CDA) in days was 272.43 ± 109.12. The mean no. of readmissions for de-addiction last 1 year was 0.23 ± 0.57 in the study population. Univariate analysis shows age at first drink in years, total duration of drinking in months and use of disulfiram and graduation as educational status are associated with higher odds of relapse. However, multiple regression model showed no statistically significant association. Conclusion: The complete abstinence was seen only in 31.43% of the population

Intervenciones basadas en mindfulness para la prevención de recaídas en el consumo de alcohol: una revisión sistemática

“…Sin embargo, las tasas de recaída se mantienen elevadas durante el primer año de abstinencia, entre el 40-60% (Korecki et al 2020) y el 65-70% (Stanley et al, 2019) y los resultados y curso de los pacientes son altamente variables (Hallgren et al, 2021. No existe el tratamiento psicológico único y definitivo que sea generalizable a amplios grupos de pacientes (Ray et al, 2019), debido a importantes obstáculos y limitaciones metodológicas en la investigación. Entre ellas destacan que los tamaños del efecto encontrados no superan el rango de pequeño a moderado, con recomendaciones débiles (Hallgren et al, 2021;Kuhlemeier et al, 2021;Magill et al, 2019), elevadas tasas de abandono (Priddy et al, 2018) y dificultades para la replicación de los estudios (Hsiao et al, 2019).…”